In this feature from Scripps News America Tonight, Phil Mounteney, Vice President of Science and Technology at Dotmatics, explores how artificial intelligence (AI) is revolutionizing scientific research and pharmaceutical drug discovery. Discover how Dotmatics Luma harnesses AI to accelerate innovation, cut costs, and reduce time-to-market, addressing the complex challenges faced by modern laboratories.
Learn More About Dotmatics
Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.